Search For "clinic"
COVID-19: Three Indian vaccines in different phases of clinical testing, s
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): At present, country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) on Tuesday.
Read More
CM Yediyurappa's condition stable in hospital
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], Aug 3 (ANI): Karnataka Chief Minister BS Yediyurappa who is undergoing treatment at the Manipal Hospital in Bengaluru after testing positive for COVID-19 is in a clinically stable condition and doing well, said the hospital on Monday.
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
No silver bullet for COVID-19 at present, there might never be: WHO
Updated : 5 years, 7 months ago IST
Geneva [Switzerland], Aug 3 (ANI): A number of coronavirus vaccines are now in phase three of clinical trials but "there's no silver bullet at the moment and there might never be," Tedros Adhanom Ghebreyesus, World Health Organisation Director-General said on Monday.
Read More
Karnataka CM in stable condition after testing positive for COVID-19: Mani
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], Aug 3 (ANI): Karnataka Chief Minister BS Yediyurappa and his daughter have been admitted to the Manipal Hospital in Bengaluru for observation after testing positive for COVID-19. The Chief Minister is in clinically stable condition.
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
Study reveals aerobic exercise could have final say on fatty livers
Updated : 5 years, 7 months ago IST
Dublin [Ireland], August 2 (ANI): A new study highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver diseases during exercise trials, rather than weight loss.
Read More
First person in US to receive a near total face transplant dies
Updated : 5 years, 7 months ago IST
Washington [US], Aug 2 (ANI): Connie Culp (57), the first person in the United States to receive a near-total face transplant, has died, CNN reported citing Cleveland Clinic, where the procedure was performed in 2008.
Read More
Text messaging shows potential as mental health therapy: Researchers
Updated : 5 years, 7 months ago IST
Washington [US], August 1 (ANI): A new study has explored a text-messaging intervention as a potential therapy to mental health issues. The study states that a text-messaging intervention, on top of normal care, can be a safe, clinically promising, feasible tool to provide support to people
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
COVID-19 vaccine development: Only 3 vaccine candidates in phase III acros
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More